Kristen K. Ciombor, MD, MSCI, associate professor of medicine at Vanderbilt University, spoke on the need for precision medicine approaches in colorectal cancer.
There is a need for precision medicine approaches in colorectal cancer, said Kristen K. Ciombor, MD, MSCI, associate professor of medicine at Vanderbilt University, speaking at an Institute for Value Based Medicine® meeting.
Transcript
How do rising rates of colorectal cancer among younger patients point to the need for precision medicine approaches in this type of cancer?
We’ve been seeing recently that colorectal cancer is increasing in the young, with the highest increased incidence in patients under 50.
Now we have so many other options other than just standard chemotherapy. We do know that next generation sequencing early on in the diagnosis can be essential in demonstrating improved outcomes when we can target these treatments specifically to the patient's tumor.
There are pretty high rates of microsatellite instability, BRAF-2, or KRAS mutations and other things that are increasingly actionable. And so, we really want to be able to offer our best therapies especially for patients who are younger with this disease.
Flatiron Health, Exact Sciences Announce Deal to Speed Evidence Generation With MRD Test
February 6th 2025The companies announced the deal in a statement February 5, 2025, noting that the first patient had enrolled in a prospective clinical study using the test to monitor cancer recurrence across multiple solid tumor types.
Read More
On World Cancer Day, NCCN Patient Advocates Share What Makes Their Journeys Unique
February 4th 2025World Cancer Day also marks the start of the ‘United by Unique’ campaign, which seeks to highlight how each person’s journey with cancer is unique, even though the patients, caregivers, and health care teams who are touched by cancer are united by shared goals.
Read More